SCHEMBL861097

SCHEMBL861097

Cc1cc(Br)cc2c1nc(C)n2C(=O)OCC(C)C

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ASAH1 Q13510 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
P2RX4 Q99571 1/20 0.33
BRD4 O60885 2/20 0.32
RORC P51449 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 1/20 0.32
KCNK3 O14649 1/20 0.32
KCNK9 Q9NPC2 1/20 0.32
EGFR P00533 1/20 0.32
TSHR P16473 1/20 0.31
TP53 P04637 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8539342 0.80 ALDH1A1 (0.45) ALDH1A1NPC1RAB9AASAH1P2RX4
SCHEMBL855641 0.79 ALDH1A1 (0.37) ALDH1A1NPC1RAB9AASAH1P2RX4
SCHEMBL855565 0.78 LCK (0.37) BRD4RORCLMNA
SCHEMBL3763758 0.76 ALDH1A1 (0.39) ALDH1A1NPC1RAB9AASAH1P2RX4
SCHEMBL862091 0.74 ALDH1A1 (0.39) ALDH1A1NPC1RAB9AASAH1P2RX4
SCHEMBL859022 0.72 ALDH1A1 (0.39) ALDH1A1NPC1RAB9AASAH1P2RX4
SCHEMBL858086 0.68 MCL1 (0.42) ALDH1A1NPC1RAB9AP2RX4LMNA
SCHEMBL6126475 0.68 MET (0.40) ALDH1A1NPC1RAB9AASAH1L3MBTL1
SCHEMBL30888966 0.68 NQO2 (0.38) EGFR
SCHEMBL21522868 0.68 NQO2 (0.38) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed
WO-2010135524-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2010-11-25 WO disclosed